MSTN and ovarian hyperstimulation syndrome: Some studies have indicated that the ALK5 receptor mediates the GDF-8 signaling pathway, and that the ALK5 inhibitor SB431542 alleviates polycystic ovarian morphology and OHSS symptoms.